We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

141 hedge funds and large institutions have $432M invested in Pacific Biosciences in 2016 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 70 increasing their positions, 27 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

159% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 27

93% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 15

9% more funds holding

Funds holding: 129 → 141 (+12)

11% less capital invested

Capital invested by funds: $487M → $432M (-$54.8M)

28% less call options, than puts

Call options by funds: $4.08M | Put options by funds: $5.66M

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
141
Holders Change
+12
Holders Change %
+9.3%
% of All Funds
3.76%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
29
Increased
70
Reduced
27
Closed
15
Calls
$4.08M
Puts
$5.66M
Net Calls
-$1.58M
Net Calls Change
-$876K

Top Buyers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$22.9M
2
RCM
Raging Capital Management
New Jersey
+$15.9M
3
BM
Bridger Management
New York
+$9.91M
4
Capital World Investors
Capital World Investors
California
+$8.15M
5
Wells Fargo
Wells Fargo
California
+$8.04M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$31.1M
2
EAM
EverPoint Asset Management
Connecticut
-$8.07M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.65M
4
Renaissance Technologies
Renaissance Technologies
New York
-$7.17M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fuller & Thaler Asset Management
26
Fuller & Thaler Asset Management
California
$2.82M – – –
BIM
27
BlackRock Investment Management
Delaware
$2.79M +$418K +45,768 +13%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.52M +$245K +26,823 +8%
BG
29
BlackRock Group
United Kingdom
$2.36M +$126K +13,766 +4%
ACH
30
ArrowMark Colorado Holdings
Colorado
$2.3M +$955K +104,486 +47%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$2.12M +$2.12M +232,335 +334%
ACP
32
Acuta Capital Partners
California
$2.11M +$1.23M +134,632 +81%
SCM
33
SG Capital Management
Illinois
$1.86M +$2.42M +264,669 New
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$1.71M -$69.4K -7,600 -3%
TCIM
35
TIAA CREF Investment Management
New York
$1.7M +$290K +31,766 +15%
TMC
36
Trellus Management Company
Florida
$1.58M +$581K +63,600 +39%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$1.53M +$1.98M +216,884 New
LCS
38
Levin Capital Strategies
New York
$1.4M -$268K -29,300 -13%
AQR Capital Management
39
AQR Capital Management
Connecticut
$1.38M +$415K +45,444 +30%
BLAM
40
Bourne Lent Asset Management
New York
$1.24M +$119K +13,000 +8%
Axa
41
Axa
France
$1.21M +$1.22M +133,400 +343%
HI
42
HBK Investments
Texas
$1.19M +$1.54M +168,500 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.12M +$108K +11,874 +8%
PPA
44
Parametric Portfolio Associates
Washington
$1.11M +$460K +50,389 +47%
Deutsche Bank
45
Deutsche Bank
Germany
$1.1M -$2.5M -273,483 -63%
Group One Trading
46
Group One Trading
Illinois
$986K -$188K -20,612 -13%
Swiss National Bank
47
Swiss National Bank
Switzerland
$975K +$280K +30,600 +28%
Charles Schwab
48
Charles Schwab
California
$952K +$176K +19,300 +17%
BlackRock
49
BlackRock
New York
$946K -$252K -27,540 -17%
CLOS
50
Compagnie Lombard Odier SCmA
Switzerland
$927K +$442K +48,400 +58%
1
2
3 4 5

PACB Hedge Fund Activity: Q2 2016 in Review

141 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q2 2016, worth a combined $432M — down 11% from $487M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PACB positions and 15 closed out — a net gain of 14 holders — while 70 added to existing stakes and 27 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $22.9M. The largest seller was Consonance Capital Management, cutting an estimated $31.1M.

  • 141 institutional investors held Pacific Biosciences (PACB) as of Q2 2016, up from 129 in Q1 2016.
  • Funds reported $432M of Pacific Biosciences stock for Q2 2016, down 11% quarter-over-quarter.
  • 29 funds opened new Pacific Biosciences positions in Q2 2016 and 15 closed out, a net change of +14 holders.
  • The largest Pacific Biosciences buyer in Q2 2016 was Lord, Abbett & Co, an estimated $22.9M added.
  • The largest Pacific Biosciences seller in Q2 2016 was Consonance Capital Management, an estimated $31.1M sold.

Based on aggregated 13F filings for Q2 2016.